Do Fat-Restricted Diets Help Sjögren-Larsson Syndrome?
At a Glance
A fat-restricted or MCT diet is not an effective treatment for Sjögren-Larsson syndrome (SLS). While it may mildly improve skin scaling, it cannot stop neurological damage like spasticity. Strict fat restriction is no longer standard care due to the high risk of childhood malnutrition.
In this answer
3 sections
To answer directly: While a diet restricted in long-chain fatty acids (LCFAs) and supplemented with medium-chain triglycerides (MCTs) was historically thought to help, current medical evidence shows it is not an effective treatment for Sjögren-Larsson syndrome (SLS). Some people notice mild improvements in skin symptoms (ichthyosis, a condition causing dry, thick, and scaly skin) on these diets, but dietary changes do not reverse, stop, or slow down the neurological damage. Because strict fat restriction can cause dangerous nutritional deficiencies—especially in growing children—these diets are not considered standard care today.
Why Diet May Mildly Improve Skin Symptoms
SLS is caused by a genetic mutation that results in a missing or defective enzyme called fatty aldehyde dehydrogenase (FALDH) [1]. Normally, FALDH breaks down fatty aldehydes and fatty alcohols. When the enzyme isn’t working properly, these toxic fatty substances accumulate in the body’s tissues [2]. In the skin, this buildup prevents the production of acylceramides, which are crucial fats that keep the skin moisturized and maintain its protective barrier [3][4].
Historically, doctors theorized that by strictly limiting LCFAs in the diet and replacing them with MCTs (which the body processes differently), they could reduce the accumulation of these toxic fatty alcohols [5]. Because a portion of the body’s fatty alcohols come from digesting dietary fats, reducing fat intake can slightly lower the total amount of these substances in the skin. This slight reduction is why some individuals experience moderate improvements in skin dryness, scaling, and thickness while on the diet.
Why Diet Cannot Stop Brain and Neurological Damage
Even if a specialized diet mildly improves the skin, it unfortunately does not improve spasticity or intellectual disability [6]. The toxic fatty aldehydes and alcohols that damage the brain are primarily produced endogenously (internally) by the body’s own natural cellular functions [7]. They are created when the brain breaks down normal internal cellular components and chemical messengers [7].
Because the brain and nervous system are creating these toxic substances from within their own cells, altering the fats you or your child eat will not prevent this internal buildup. Over time, this buildup causes complex damage, particularly to the brain’s white matter (the nerve pathways that connect brain regions) [8]. This leads to spasticity and learning challenges that cannot be reversed by diet.
Risks and Modern Alternatives
Everyone needs a steady supply of fats for healthy overall brain function, hormone production, and energy. Placing a child or adult on a strict fat-restricted diet carries significant risks of malnutrition and poor growth, which usually outweigh any mild skin benefits [9]. If you are considering any dietary adjustments, they must be strictly supervised by a specialized metabolic dietitian to ensure you or your child are getting the necessary nutrients.
Today, standard clinical care focuses on directly managing symptoms rather than restricting diet. Care is typically overseen by a neurologist and a metabolic geneticist:
- For the skin: Using topical keratolytic creams (which help break down and shed the thick, scaly outer layers of skin) and thick emollients to manage the ichthyosis [6].
- For the muscles: Using physical therapy to maintain mobility and prevent permanent joint stiffness, bracing, and medications like intrathecal baclofen (a muscle relaxant delivered directly to the spinal fluid) to reduce muscle spasticity [10].
- Future therapies: Researchers are currently running clinical trials for new “aldehyde-scavenging” drugs. Instead of changing the diet, these investigational medications are designed to directly neutralize the toxic substances in the body [11][12]. You can ask your geneticist or check resources like ClinicalTrials.gov to see if you or your child might be eligible for upcoming trials.
Common questions in this guide
Does an MCT diet improve neurological symptoms in Sjögren-Larsson syndrome?
Why do doctors no longer recommend a strict fat-restricted diet for SLS?
Can diet help with the ichthyosis and skin scaling in SLS?
What are the current treatments for muscle spasticity in Sjögren-Larsson syndrome?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given the current stage of my (or my child's) neurological symptoms, am I a candidate for therapies like intrathecal baclofen to help manage spasticity?
- 2.Can you refer us to a specialized metabolic dietitian to evaluate our current diet and ensure there are no nutritional deficiencies?
- 3.Are there any active clinical trials for aldehyde-scavenging drugs for which we might be eligible, and how can we get screened?
- 4.Which specific topical keratolytic creams and emollients do you recommend for managing the ichthyosis without causing skin irritation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Genotype and phenotype variability in Sjögren-Larsson syndrome.
Weustenfeld M, Eidelpes R, Schmuth M, et al.
Human mutation 2019; (40(2)):177-186 doi:10.1002/humu.23679.
PMID: 30372562 - 2
Beyond retina in Sjogren-Larsson syndrome.
Pawar N, Meenakshi R, Maheshwari D, et al.
Indian journal of ophthalmology 2022; (70(7)):2727-2728 doi:10.4103/ijo.IJO_2994_21.
PMID: 35791223 - 3
Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome.
Nojiri K, Fudetani S, Arai A, et al.
Molecular and cellular biology 2021; (41(10)):e0035221 doi:10.1128/MCB.00352-21.
PMID: 34370553 - 4
Ceramide profiling of stratum corneum in Sjögren-Larsson syndrome.
Arai A, Takeichi T, Wakamoto H, et al.
Journal of dermatological science 2022; (107(3)):114-122 doi:10.1016/j.jdermsci.2022.08.003.
PMID: 35973883 - 5
Sjögren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma.
Rizzo WB, Craft DA
Journal of lipid research 2000; (41(7)):1077-81.
PMID: 10884288 - 6
Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.
Vural S, Vural A, Akçimen F, et al.
International journal of dermatology 2018; (57(7)):843-848 doi:10.1111/ijd.14013.
PMID: 29704247 - 7
Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Rizzo WB
Molecular genetics and metabolism 2007; (90(1)):1-9 doi:10.1016/j.ymgme.2006.08.006.
PMID: 16996289 - 8
Sjogren-Larsson syndrome brain volumetric reductions demonstrated with an automated software.
Castro JTS, Saab CL, Souto MPA, et al.
Arquivos de neuro-psiquiatria 2023; (81(9)):809-815 doi:10.1055/s-0043-1772601.
PMID: 37793403 - 9
Sjogren-Larsson Syndrome: Mechanisms and Management.
Bindu PS
The application of clinical genetics 2020; (13()):13-24 doi:10.2147/TACG.S193969.
PMID: 32021380 - 10
Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome.
Hidalgo ET, Orillac C, Hersh A, et al.
Journal of child neurology 2017; (32(1)):100-103 doi:10.1177/0883073816671440.
PMID: 28257279 - 11
Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.
Rizzo WB
Expert opinion on orphan drugs 2016; (4(4)):395-406 doi:10.1517/21678707.2016.1154453.
PMID: 27547594 - 12
Sjögren-Larsson syndrome: A biochemical rationale for using aldehyde-reactive therapeutic agents.
Rizzo WB, S'aulis D, Dorwart E, Bailey Z
Molecular genetics and metabolism reports 2022; (30()):100839 doi:10.1016/j.ymgmr.2021.100839.
PMID: 35242571
This page provides educational information about diet and Sjögren-Larsson syndrome. Dietary changes carry risks of malnutrition and should always be supervised by a specialized metabolic dietitian and your medical team.
Get notified when new evidence is published on Sjögren-Larsson syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.